DIA Biosimilars 2013

Biogen Idec

Biogen, Novo Nordisk collaborate with Adimab

Tuesday, August 30, 2011 02:36 PM

Adimab has initiated two independent collaborations with Biogen Idec and Novo Nordisk.

More... »

Cenduit: Now with Patient Reminders

Avila names Hirsch CFO

Tuesday, July 12, 2011 10:14 AM

Avila Therapeutics, a biotechnology company developing targeted covalent drugs, has named Andrew Hirsch its first chief financial officer.

More... »

CRF Health – eCOA Forum

Teva, Biogen reveal positive results for MS drugs

Wednesday, April 13, 2011 12:49 PM

Teva and Biogen Idec have presented late-stage data on their respective oral offerings for the treatment of multiple sclerosis (MS), according to Pharma Times.

More... »

Manning, Chang new appointments at Aileron

Tuesday, April 12, 2011 12:35 PM

CAMBRIDGE, Mass.-based Aileron Therapeutics, a biopharmaceutical company that has developed a new class of drugs called stapled peptides, has appointed Anthony M. Manning, Ph.D., to senior vice president of research and preclinical development and Yong S. Chang, Ph.D., to head of biology.

More... »

Biogen signs license agreement with PharmaPros

Tuesday, March 22, 2011 11:57 AM

Biogen Idec has signed a three-year enterprise license for PharmaPros' automated study management solution, Dataflow Manager. The deal includes unlimited studies and unlimited users for the duration of the license.

More... »

Biogen Idec, GNS target personalized medicine

Thursday, March 17, 2011 11:53 AM

Using a patient dataset and high-horsepower computing, researchers at Biogen Idec and analytics company GNS Healthcare have built a rheumatoid arthritis disease model that lets them run patient-specific virtual clinical trials, according to Fierce Biotech IT. This personalized-medicine stepping stone yields dynamic disease models of individualized patient outcomes.

More... »

Biogen adds to portfolio

Monday, March 7, 2011 02:03 PM

Biogen Idec, which makes multiple sclerosis drugs Tysabri and Avonex, plans to build a portfolio of products to treat noncancerous blood disorders, according to Reuters.

More... »

The CenterWatch Monthly October 2010

Friday, October 1, 2010 09:04 AM

Anticipating disruptions from sponsor M&As and consolidations

More... »

CenterWatch Drugs in Clinical Trials Database Library. Drug intelligence right at your fingertips.
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

Copyright © 1995-2013 CenterWatch.